|
RUFY2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.695600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.317600E-03 |
| Normal-vs-Stage2 |
1.622040E-01 |
| Normal-vs-Stage3 |
7.238000E-03 |
| Normal-vs-Stage4 |
5.817600E-02 |
| Stage1-vs-Stage2 |
7.421000E-01 |
| Stage1-vs-Stage3 |
5.069200E-01 |
| Stage1-vs-Stage4 |
8.733600E-01 |
| Stage2-vs-Stage3 |
4.413000E-01 |
| Stage2-vs-Stage4 |
6.903600E-01 |
| Stage3-vs-Stage4 |
8.162000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.818700E-03 |
| Normal-vs-AfricanAmerican |
2.391000E-01 |
| Normal-vs-Asian |
1.237650E-01 |
| Caucasian-vs-AfricanAmerican |
1.605220E-01 |
| Caucasian-vs-Asian |
8.635000E-01 |
| AfricanAmerican-vs-Asian |
5.536200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.243300E-03 |
| Normal-vs-Female |
9.346600E-01 |
| Male-vs-Female |
1.595450E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.974200E-02 |
| Normal-vs-Extreme_Weight |
1.516210E-03 |
| Normal-vs-Obese |
1.141600E-01 |
| Normal-vs-Extreme_Obese |
2.220200E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.217000E-01 |
| Normal_Weight-vs-Obese |
5.654200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.591600E-01 |
| Extreme_Weight-vs-Obese |
6.487600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.350000E-01 |
| Obese-vs-Extreme_Obese |
3.144600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.502000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.846640E-01 |
| Normal-vs-Age(61-80Yrs) |
5.605700E-04 |
| Normal-vs-Age(81-100Yrs) |
5.950900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.994600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.415860E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.577700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.975300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.509700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.106400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.950500E-02 |
| Normal-VS-Type2 PRCC |
3.77010000000011E-05 |
| Normal-VS-KIRP CIMP |
9.095800E-01 |
| Normal-VS-Unclassified PRCC |
1.836780E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.163060E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.146600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.618600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.702100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.603940E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.713400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.764780E-04 |
| Normal-vs-N1 |
3.000000E-01 |
| Normal-vs-N2 |
7.992200E-02 |
| N0-vs-N1 |
9.776000E-02 |
| N0-vs-N2 |
8.966400E-01 |
| N1-vs-N2 |
4.189800E-01 |
|
|
